Schulze A, Jensch I, Krauel K, et al. New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cells. Thrombosis research. 2014;134(1):174–81. http://www.sciencedirect.com/science/article/pii/S004938481400228X
Kreimann M, Brandt S, Krauel K, et al. Binding of anti-platelet factor 4/heparin antibodies depends on the thermodynamics of conformational changes in platelet factor 4. Blood. 2014;124(15):2442–9. http://www.bloodjournal.org/content/124/15/2442.long
Jaax ME, Krauel K, Marschall T, et al. Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood. 2013;122(2):272–81. http://www.bloodjournal.org/content/122/2/272.long
Krauel K, Hackbarth C, Fürll B, et al. Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies. Blood. 2012;119(5):1248–55. http://www.bloodjournal.org/content/119/5/1248.long
Krauel K, Pӧtschke C, Weber C, et al. Platelet factor 4 binds to bacteria, inducing antibodies cross-reacting with the major antigen in heparin-induced thrombocytopenia. Blood. 2011;117(4):1370–8. http://www.bloodjournal.org/content/117/4/1370.long
Greinacher A, Holtfreter B, Krauel K, et al. Association of natural anti-platelet factor 4/heparin antibodies with periodontal disease. Blood. 2011;118(5):1395–401. http://www.bloodjournal.org/content/118/5/1395.long
Selleng K, Schütt A, Selleng S, et al. Studies of the anti-platelet factor 4/heparin immune response: adapting the enzyme-linked immunosorbent spot assay for detection of memory B cells against complex antigens. Transfusion. 2010;50(1):32–9. http://onlinelibrary.wiley.com/doi/10.1111/j.1537-2995.2009.02360.x/abstract
Koenen RR, von Hundelshausen P, Nesmelova IV, et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nature medicine. 2009;15(1):97–103. http://www.nature.com/nm/journal/v15/n1/full/nm.1898.html
Xiao Z, Visentin GP, Dayananda KM, et al. Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion. Blood. 2008;112(4):1091–100. http://www.bloodjournal.org/content/112/4/1091.long
Krauel K, Fürll B, Warkentin T, et al. Heparin-induced thrombocytopenia-therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. Journal of Thrombosis and Haemostasis. 2008;6(12):2160–7. http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2008.03171.x/abstract
Schenk S, EL-BANAYOSY A, Morshuis M, et al. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. Journal of Thrombosis and Haemostasis. 2007;5(2):235–41. http://onlinelibrary.wiley.com/doi/10.1111/j.1538-7836.2007.02295.x/abstract
Greinacher A, Gopinadhan M, Günther J-U, et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arteriosclerosis, thrombosis, and vascular biology. 2006;26(10):2386–93. http://atvb.ahajournals.org/content/26/10/2386.long
Juhl D, Eichler P, Lubenow N, et al. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. European journal of haematology. 2006;76(5):420–6. http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0609.2005.00621.x/abstract
Schirrmeister J, Zocher S, Flor L, et al. The domain of unknown function DUF1521 exhibits metal ion-inducible autocleavage activity-a novel example from a putative effector protein of Vibrio coralliilyticus ATCC BAA-450. FEMS microbiology letters. 2013;343(2):177–82. http://femsle.oxfordjournals.org/content/femsle/343/2/177.full.pdf
Schramm G, Falcone FH, Gronow A, et al. Molecular characterization of an interleukin-4-inducing factor from Schistosoma mansoni eggs. Journal of Biological Chemistry. 2003;278(20):18384–92. http://www.jbc.org/content/278/20/18384.long
Antelmann H, Tjalsma H, Voigt B, et al. A proteomic view on genome-based signal peptide predictions. Genome Research. 2001;11(9):1484–502. http://genome.cshlp.org/content/11/9/1484.long
Maldi-TOF - Mass Spectrometry
Cassara M, Menzel V, Hinsch K, et al. Voltage-dependent anion channels 1 and 2 are expressed in porcine oocytes. Bioscience reports. 2010;30:193–200. http://www.bioscirep.org/content/30/3/193
Yiallouros I, Kappelhoff R, Schilling O, et al. Activation mechanism of pro-astacin: role of the pro-peptide, tryptic and autoproteolytic cleavage and importance of precise amino-terminal processing. Journal of molecular biology. 2002;324(2):237–46. http://www.sciencedirect.com/science/article/pii/S0022283602011026